Equibles does not estimate personal net worth.
Get an email with a short summary when Olema Pharmaceuticals, Inc. publishes a filing, an earnings call transcript or a press release.
Get OLMA alertsSean Bohen is recorded as CEO and Board Member at Olema Pharmaceuticals, Inc. (OLMA). The newest filing on record that lists Sean Bohen as CEO and Board Member at Olema Pharmaceuticals, Inc. (OLMA) is dated April 29, 2026. Sean Bohen has spoken on 1 earnings call and 3 other investor events across 1 company, most recently for Olema Pharmaceuticals, Inc. on September 15, 2026. Olema Pharmaceuticals, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Olema Pharmaceuticals, Inc. includes Jason O'Byrne (CFO and Chief Accounting Officer), Dr. Prakash Raman (Board Member), Prakash Raman (Board Member) and 1 other.
“Yeah, so thank you, first of all, for the opportunity and the people here for listening to the Olima story. I think there are a number of reasons why lumping these molecules together is a mistake.”
“Well, thanks, everyone, for your interest. Just reminding you, Lima is a company focused on changing the treatment paradigm for ER-positive, HER2-negative breast cancer.”
“And thanks for the opportunity to share that. So we had a poster on Saturday, a very well-attended poster on our Phase I single-agent dose escalation for OP3136.”
“Well, thanks, everyone, for your interest. Just reminding you, Lima is a company focused on changing the treatment paradigm for ER-positive, HER2-negative breast cancer.”
2026-01-30–present
Start not stated–present
Last confirmed April 29, 2026
Start not stated–present
Last confirmed April 29, 2026
Biotechnology · Healthcare
CEO, Board Member
2026-01-30–present
